• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PLK1 在 DNA 损伤和有丝分裂进程中靶向 NOTCH1。

PLK1 targets NOTCH1 during DNA damage and mitotic progression.

机构信息

Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena 291, 00161 Rome, Italy.

Center of Life Nano Science Sapienza, Istituto Italiano di Tecnologia, 00161 Rome, Italy.

出版信息

J Biol Chem. 2019 Nov 22;294(47):17941-17950. doi: 10.1074/jbc.RA119.009881. Epub 2019 Oct 9.

DOI:10.1074/jbc.RA119.009881
PMID:31597699
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6879332/
Abstract

Notch signaling plays a complex role in carcinogenesis, and its signaling pathway has both tumor suppressor and oncogenic components. To identify regulators that might control this dual activity of NOTCH1, we screened a chemical library targeting kinases and identified Polo-like kinase 1 (PLK1) as one of the kinases involved in arsenite-induced NOTCH1 down-modulation. As PLK1 activity drives mitotic entry but also is inhibited after DNA damage, we investigated the PLK1-NOTCH1 interplay in the G phase of the cell cycle and in response to DNA damage. Here, we found that PLK1 regulates NOTCH1 expression at G/M transition. However, when cells in G phase are challenged with DNA damage, PLK1 is inhibited to prevent entry into mitosis. Interestingly, we found that the interaction between NOTCH1 and PLK1 is functionally important during the DNA damage response, as we found that whereas PLK1 activity is inhibited, NOTCH1 expression is maintained during DNA damage response. During genotoxic stress, cellular transformation requires that promitotic activity must override DNA damage checkpoint signaling to drive proliferation. Interestingly, we found that arsenite-induced genotoxic stress causes a PLK1-dependent signaling response that antagonizes the involvement of NOTCH1 in the DNA damage checkpoint. Taken together, our data provide evidence that Notch signaling is altered but not abolished in SCC cells. Thus, it is also important to recognize that Notch plasticity might be modulated and could represent a key determinant to switch on/off either the oncogenic or tumor suppressor function of Notch signaling in a single type of tumor.

摘要

Notch 信号通路在肿瘤发生中发挥着复杂的作用,其信号通路既有肿瘤抑制因子又有致癌因子。为了鉴定可能控制 NOTCH1 这种双重活性的调节剂,我们筛选了针对激酶的化学文库,发现 Polo 样激酶 1(PLK1)是参与亚砷酸盐诱导 NOTCH1 下调的激酶之一。由于 PLK1 活性驱动有丝分裂进入,但在 DNA 损伤后也被抑制,我们研究了 PLK1-NOTCH1 在细胞周期 G 期和响应 DNA 损伤时的相互作用。在这里,我们发现 PLK1 在 G/M 转换时调节 NOTCH1 的表达。然而,当 G 期的细胞受到 DNA 损伤的挑战时,PLK1 被抑制以防止进入有丝分裂。有趣的是,我们发现 NOTCH1 和 PLK1 之间的相互作用在 DNA 损伤反应中具有功能重要性,因为我们发现,虽然 PLK1 活性受到抑制,但 NOTCH1 的表达在 DNA 损伤反应期间得以维持。在遗传毒性应激下,细胞转化需要促有丝分裂活性必须克服 DNA 损伤检查点信号,以驱动增殖。有趣的是,我们发现亚砷酸盐诱导的遗传毒性应激会引起依赖于 PLK1 的信号反应,该反应拮抗 NOTCH1 参与 DNA 损伤检查点。总之,我们的数据提供了证据表明 Notch 信号在 SCC 细胞中发生了改变但并未完全消除。因此,同样重要的是要认识到 Notch 可塑性可能被调节,并且可能成为在单一类型肿瘤中打开/关闭 Notch 信号的致癌或肿瘤抑制功能的关键决定因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23d4/6879332/a8b55556fdba/zbc9991914760007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23d4/6879332/cf1e664b05a1/zbc9991914760001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23d4/6879332/9cae1a36a2da/zbc9991914760002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23d4/6879332/221bb122a6f2/zbc9991914760003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23d4/6879332/f33e94b7d7fd/zbc9991914760004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23d4/6879332/38cf7b1c2ebf/zbc9991914760005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23d4/6879332/545f5cb99412/zbc9991914760006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23d4/6879332/a8b55556fdba/zbc9991914760007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23d4/6879332/cf1e664b05a1/zbc9991914760001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23d4/6879332/9cae1a36a2da/zbc9991914760002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23d4/6879332/221bb122a6f2/zbc9991914760003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23d4/6879332/f33e94b7d7fd/zbc9991914760004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23d4/6879332/38cf7b1c2ebf/zbc9991914760005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23d4/6879332/545f5cb99412/zbc9991914760006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23d4/6879332/a8b55556fdba/zbc9991914760007.jpg

相似文献

1
PLK1 targets NOTCH1 during DNA damage and mitotic progression.PLK1 在 DNA 损伤和有丝分裂进程中靶向 NOTCH1。
J Biol Chem. 2019 Nov 22;294(47):17941-17950. doi: 10.1074/jbc.RA119.009881. Epub 2019 Oct 9.
2
Phosphorylation of Plk1 at S137 and T210 is inhibited in response to DNA damage.响应DNA损伤时,Plk1在S137和T210位点的磷酸化受到抑制。
Cell Cycle. 2005 Jan;4(1):166-71. doi: 10.4161/cc.4.1.1348. Epub 2005 Jan 5.
3
A specific inhibitor of polo-like kinase 1, GSK461364A, suppresses proliferation of Raji Burkitt's lymphoma cells through mediating cell cycle arrest, DNA damage, and apoptosis.一种特定的 Polo 样激酶 1 抑制剂 GSK461364A 通过介导细胞周期阻滞、DNA 损伤和细胞凋亡抑制 Raji 伯基特淋巴瘤细胞的增殖。
Chem Biol Interact. 2020 Dec 1;332:109288. doi: 10.1016/j.cbi.2020.109288. Epub 2020 Oct 17.
4
Regulation of Polo-like kinase 1 by DNA damage in mitosis. Inhibition of mitotic PLK-1 by protein phosphatase 2A.有丝分裂中DNA损伤对Polo样激酶1的调控。蛋白磷酸酶2A对有丝分裂期PLK-1的抑制作用。
J Biol Chem. 2007 Jan 26;282(4):2473-82. doi: 10.1074/jbc.M605480200. Epub 2006 Nov 22.
5
Polo-like kinase 1 inhibitors, mitotic stress and the tumor suppressor p53.Polo-like 激酶 1 抑制剂、有丝分裂应激和肿瘤抑制因子 p53。
Cell Cycle. 2013 May 1;12(9):1340-51. doi: 10.4161/cc.24573. Epub 2013 Apr 10.
6
FRET-Based Sorting of Live Cells Reveals Shifted Balance between PLK1 and CDK1 Activities During Checkpoint Recovery.基于 FRET 的活细胞分选揭示了在检查点恢复过程中 PLK1 和 CDK1 活性之间的平衡转移。
Cells. 2020 Sep 19;9(9):2126. doi: 10.3390/cells9092126.
7
PLK1 Inhibition Targets Myc-Activated Malignant Glioma Cells Irrespective of Mismatch Repair Deficiency-Mediated Acquired Resistance to Temozolomide.PLK1 抑制靶向 Myc 激活的恶性神经胶质瘤细胞,而与错配修复缺陷介导的替莫唑胺获得性耐药无关。
Mol Cancer Ther. 2018 Dec;17(12):2551-2563. doi: 10.1158/1535-7163.MCT-18-0177. Epub 2018 Sep 14.
8
Mitotic DNA damage response: Polo-like kinase-1 is dephosphorylated through ATM-Chk1 pathway.有丝分裂 DNA 损伤反应:Polo 样激酶-1 通过 ATM-Chk1 途径去磷酸化。
Cell Cycle. 2010 Jun 15;9(12):2389-98. doi: 10.4161/cc.9.12.11904.
9
Polo-like kinase 1 inactivation following mitotic DNA damaging treatments is independent of ataxia telangiectasia mutated kinase.有丝分裂期DNA损伤处理后Polo样激酶1的失活与共济失调毛细血管扩张症突变激酶无关。
Mol Cancer Res. 2004 Jul;2(7):417-26.
10
A mitotic phosphorylation feedback network connects Cdk1, Plk1, 53BP1, and Chk2 to inactivate the G(2)/M DNA damage checkpoint.一个有丝分裂磷酸化反馈网络将 Cdk1、Plk1、53BP1 和 Chk2 连接起来,使 G(2)/M DNA 损伤检查点失活。
PLoS Biol. 2010 Jan 26;8(1):e1000287. doi: 10.1371/journal.pbio.1000287.

引用本文的文献

1
NOD2 reduces the chemoresistance of melanoma by inhibiting the TYMS/PLK1 signaling axis.NOD2 通过抑制 TYMS/PLK1 信号轴降低黑色素瘤的化疗耐药性。
Cell Death Dis. 2024 Oct 1;15(10):720. doi: 10.1038/s41419-024-07104-8.
2
PLK1 maintains DNA methylation and cell viability by regulating phosphorylation-dependent UHRF1 protein stability.PLK1通过调节磷酸化依赖性UHRF1蛋白稳定性来维持DNA甲基化和细胞活力。
Cell Death Discov. 2023 Oct 3;9(1):367. doi: 10.1038/s41420-023-01667-9.
3
PAK2 is essential for chromosome alignment in metaphase I oocytes.

本文引用的文献

1
DNA Damage Stress: Cui Prodest?DNA 损伤应激:谁受益?
Int J Mol Sci. 2019 Mar 1;20(5):1073. doi: 10.3390/ijms20051073.
2
Cancer Cells Exploit Notch Signaling to Redefine a Supportive Cytokine Milieu.癌细胞利用 Notch 信号重新定义支持性细胞因子微环境。
Front Immunol. 2018 Aug 14;9:1823. doi: 10.3389/fimmu.2018.01823. eCollection 2018.
3
The CDK-PLK1 axis targets the DNA damage checkpoint sensor protein RAD9 to promote cell proliferation and tolerance to genotoxic stress.CDK-PLK1 轴将 DNA 损伤检查点传感器蛋白 RAD9 作为靶点,以促进细胞增殖和耐受遗传毒性应激。
PAK2 对于减数分裂 I 期卵母细胞中的染色体排列至关重要。
Cell Death Dis. 2023 Feb 22;14(2):150. doi: 10.1038/s41419-023-05585-7.
4
Regulation Networks of Non-Coding RNA-Associated ceRNAs in Cisplatin-Induced Acute Kidney Injury.环状 RNA 在顺铂诱导的急性肾损伤中的作用及其调控机制。
Cells. 2022 Sep 23;11(19):2971. doi: 10.3390/cells11192971.
5
Small Interfering RNA in Colorectal Cancer Liver Metastasis Therapy.小干扰 RNA 在结直肠癌肝转移治疗中的应用。
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221103318. doi: 10.1177/15330338221103318.
6
The Disassociation of the A20/HSP90 Complex Downregulation of HSP90 Restores the Effect of A20 Enhancing the Sensitivity of Hepatocellular Carcinoma Cells to Molecular Targeted Agents.A20/HSP90复合物的解离:HSP90的下调恢复了A20增强肝癌细胞对分子靶向药物敏感性的作用。
Front Oncol. 2021 Dec 15;11:804412. doi: 10.3389/fonc.2021.804412. eCollection 2021.
7
Functional cooperation between ASK1 and p21 in the balance of cell-cycle arrest, cell death and tumorigenesis of stressed keratinocytes.在应激角质形成细胞的细胞周期阻滞、细胞死亡和肿瘤发生平衡中,ASK1与p21之间的功能协同作用。
Cell Death Discov. 2021 Apr 12;7(1):75. doi: 10.1038/s41420-021-00459-3.
8
SKA3 Promotes Cell Growth in Breast Cancer by Inhibiting PLK-1 Protein Degradation.SKA3 通过抑制 PLK-1 蛋白降解促进乳腺癌细胞生长。
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820947488. doi: 10.1177/1533033820947488.
9
The Impact of the Ubiquitin System in the Pathogenesis of Squamous Cell Carcinomas.泛素系统在鳞状细胞癌发病机制中的作用
Cancers (Basel). 2020 Jun 16;12(6):1595. doi: 10.3390/cancers12061595.
10
PLK1 regulates hepatic stellate cell activation and liver fibrosis through Wnt/β-catenin signalling pathway.PLK1 通过 Wnt/β-catenin 信号通路调节肝星状细胞活化和肝纤维化。
J Cell Mol Med. 2020 Jul;24(13):7405-7416. doi: 10.1111/jcmm.15356. Epub 2020 May 28.
Elife. 2017 Dec 19;6:e29953. doi: 10.7554/eLife.29953.
4
Notch as a tumour suppressor.Notch 作为一种肿瘤抑制因子。
Nat Rev Cancer. 2017 Mar;17(3):145-159. doi: 10.1038/nrc.2016.145. Epub 2017 Feb 3.
5
Plk1 Inhibitors in Cancer Therapy: From Laboratory to Clinics.Plk1抑制剂在癌症治疗中的应用:从实验室到临床
Mol Cancer Ther. 2016 Jul;15(7):1427-35. doi: 10.1158/1535-7163.MCT-15-0897. Epub 2016 Jun 21.
6
The Notch intracellular domain integrates signals from Wnt, Hedgehog, TGFβ/BMP and hypoxia pathways.Notch细胞内结构域整合来自Wnt、Hedgehog、TGFβ/BMP和缺氧信号通路的信号。
Biochim Biophys Acta. 2016 Feb;1863(2):303-13. doi: 10.1016/j.bbamcr.2015.11.020. Epub 2015 Nov 22.
7
The deregulated expression of miR-125b in acute myeloid leukemia is dependent on the transcription factor C/EBPα.急性髓系白血病中miR-125b的表达失调依赖于转录因子C/EBPα。
Leukemia. 2015 Dec;29(12):2442-5. doi: 10.1038/leu.2015.117. Epub 2015 May 18.
8
Understanding the Polo Kinase machine.了解Polo激酶机制。
Oncogene. 2015 Sep 10;34(37):4799-807. doi: 10.1038/onc.2014.451. Epub 2015 Jan 26.
9
Tumor suppression by the Fbw7 ubiquitin ligase: mechanisms and opportunities.Fbw7泛素连接酶的肿瘤抑制作用:机制与机遇
Cancer Cell. 2014 Oct 13;26(4):455-64. doi: 10.1016/j.ccell.2014.09.013.
10
Loss of Notch1-dependent p21(Waf1/Cip1) expression influences the Notch1 outcome in tumorigenesis.Notch1依赖性p21(Waf1/Cip1)表达的缺失影响肿瘤发生过程中的Notch1结果。
Cell Cycle. 2014;13(13):2046-55. doi: 10.4161/cc.29079. Epub 2014 May 6.